taining sodium calcein as a model penetrant were prepared using a mixture of mono-, di-, and tri-esters 1 and monoesters 2, composed of erythritol and phytanylacetic acid. The permeation profiles of this model compound were measured using excised hairless rat skin and a three-dimensional cultured human-skin model 24 , living skin equivalenthigh LSE-high , to evaluate the effects of the LC structures. Two kinds of LC were used to make aqueous dispersions.
EXPERIMENTAL PROCEDURES 2.1 Materials
Erythritol and sodium calcein 623 Da, log K ow 3.5 were purchased from Tokyo Chemical Industries Co., Ltd.
Tokyo, Japan . t-Butyl methyl ether was purchased from Kanto Chemical Co., Inc. Tokyo, Japan . Methyl 5,9,13,17-tetramethyloctadecanoate was prepared by the Johnson transfer reaction. EDTA 2Na was obtained from Dojin Molecular Technologies, Inc. Mashiki, Kumamoto, Japan . A surfactant, Pluronic F127, was purchased from BASF Ludwigshafen, Germany . Other reagents and solvents were of special grade or HPLC grade and used without further purifi cation.
2.2 Preparation of a mixture of mono-, di-, and tri-esters 1 and monoesters 2, composed of erythritol and phytanylacetic acid Erythritol 2.50 kg was dissolved in dimethyl sulfoxide 10.8 kg at 100 under nitrogen purging before addition of anhydrous CaCO 3 37.8 g at 80 . Methyl phytanylacetate 5,9,13,17-tetramethyloctadecanoate 4.83 kg was added dropwise to the solution under reduced pressure over 2.5 h. The reaction mixture was refluxed under reduced pressure overnight, while the methanol produced was gradually removed by distillation. After cooling, the mixture was neutralized by addition of formic acid 29 g , and concentrated in vacuo. The residue 6.1 kg was diluted with t-butyl methyl ether 18.3 kg , and filtered to remove the remaining erythritol. The filtrate was diluted again with t-butyl methyl ether 24 kg , washed twice with aqueous NaHCO 3 , and concentrated in vacuo at 100 . The product obtained 4.7 kg, 1 consisted of monoesters 36 , diesters 12 , and triesters 52 of erythritol and phytanylacetic acid the ratio was determined by GC analysis . The mixture 1 was purifi ed by column chromatography using silica gel Wakogel C-300; Wako Pure Chemicals Co., Ltd., Osaka, Japan to afford monoesters 2 of 1-Oand 2-O-phytanylacetylerythritol .
Experimental animals and three-dimensional cultured
human-skin models Male hairless rats WBM/ILA-Ht, 200-250 g b.w. were obtained from the Life Science Research Center, Josai University Sakado, Saitama, Japan or Ishikawa Experimental Laboratories Fukaya, Saitama, Japan . Animal breeding and experiments were conducted according to the Josai University guidelines.
A three-dimensional cultured human-skin model, Living Skin Equivalent-high LSE-high 24 , was obtained from Toyobo Osaka, Japan . Table 1 shows the prescriptions for liquid crystal A LC-A and liquid crystal B LC-B nanodispersions. Ten grams of crude ester 1 or pure ester 2 were used to prepare LC-A and LC-B, respectively. In this step, LC-A and LC-B were semisolid and were nanodispersed, using a high pressure emulsifi er NM2-L200AR; Yoshida Kikai Co., Ltd, Nagoya, Japan or an ultrasonic homogenizer USP-50; Shimadzu Corp., Kyoto, Japan , in an aqueous solution 90.0 2.5 Measurement of physical properties of liquid crystals 2.5.1 X-ray analysis X-ray diffraction analyses were performed on a small-angle X-ray diffraction system SAXSess equipped with a temperature controller TCS 120 , a PW3830 X-ray generator Cu-Kα, 0.1542 nm wavelength AntonPaar Japan Co., Ltd., Tokyo, Japan , and an image plate detector Perkin Elmer Japan Co., Ltd., Yokohama, Japan . Diffraction analyses were performed using a vacuum-resistant glass capillary cell at 25 for 2 h. The obtained SAXS patterns were plotted against the scattering vector length, q 4π/λ sin θ/2 , where θ is the scattering angle. The scattering intensity was normalized by the decayed direct beam intensity.
Preparation of liquid-crystal dispersions

Observations by cryo-TEM
The prepared LC dispersions were observed by cryotransmission electron microscopy cryo-TEM JEM-2011, JEOL Ltd., Akishima, Tokyo, Japan . LC dispersion samples for cryo-TEM observations were rapidly frozen on a microgrid with 1-5 μm pores at approximately 175 , with ethane as the freezing solvent, using a rapid freezing system Leica Microsystems Japan, Tokyo, Japan . The observations were performed at Terrabase Co., Ltd. Okazaki, Aichi, Japan .
Determination of calcein entrapping ratios
The calcein entrapping ratios in LC-A and LC-B were determined using a centrifuge CS100GXII; Hitachi Koki Co., Ltd., Tokyo, Japan . LC-A or LC-B 1.0 mL in a tube was placed in an angle rotor S120 AT2; Hitachi Koki Co., Ltd. . After centrifugation, the external phase aqueous phase , which separated from the LC phase, was withdrawn and the amount of calcein was determined, after adequately diluting with pH 7.4 phosphate buffer containing 1 mM EDTA 2Na, at 488 nm and 515 nm excitation and emission wavelengths, respectively, by a fl uorescence spectrophotometer RF-5300PC; Shimadzu Corp., Kyoto, Japan .
The entrapping ratio was determined by the following equation: Entrapped ratio w/w total drug amount drug amount in external phase total drug amount 100 1 2.5.4 Measurement of droplet diameter of liquid-crystal dispersions The prepared LC dispersions were diluted with distilled water; 1.0 mL was transferred to a disposable plastic cell set in a Zeta Sizer 3000HSA Otsuka Electronics Co., Ltd., Hirakata, Osaka, Japan to determine the droplet diameter by dynamic light scattering.
In vitro skin-permeation experiments
We selected three types of membrane-intact and stripped hairless rat skins, and LSE-high-to evaluate the enhancement effect of the LC formulations. These membranes represented healthy intact skin, damaged skin, and appendage-free skin. The left and right sides of the abdominal skin were excised from hairless rats under anesthesia using i.p. injections of sodium pentobarbital 50 mg/kg . Stripped skin was prepared by tape-stripping the stratum corneum 20 times using adhesive cellophane tape Nichiban Co., Ltd., Tokyo, Japan . After excising the skin, superfl uous subcutaneous fat was carefully trimmed off. The three-dimensional cultured human-skin model, LSE-high, was washed with physiological saline and separated from the well.
Each obtained skin membrane was set in a Franz-type diffusion cell with an effective diffusion area of 1.77 cm 2 or 0.78 cm 2 for hairless rat skin or LSE-high, respectively. To decrease the endogenous fl uorescence of the skin and the dryness of the stratum corneum, 1.0 mL of physiological saline and 6 mL of pH 7.4 phosphate buffer containing 1.0 mM EDTA 2Na were added to the stratum corneum and dermis side, respectively, and the skin sample was maintained for 1.0 h. Calcein 1.0 mL and fresh buffer 6.0 mL were then placed on each side of the skin to start the permeation experiments. The system was maintained at 32 , and the receiver compartment was agitated by a magnetic stirrer. The receiver sample 0.5 mL was periodically sampled to measure the skin permeation of calcein, and an equivalent volume of saline was added to keep the volume constant.
Determination of calcein concentration
The receiver sample was centrifuged and diluted with pH 7.4 phosphate buffer containing 1.0 mM EDTA 2Na. The calcein concentration in the sample was determined by fl uorescence spectrophotometry, as described in section 2.5.3 .
Determination of permeation parameters
The rate-limiting steps of calcein permeation through hairless rat skin and LSE-high are permeation through the stratum corneum and permeation through the whole epidermis, respectively 24 . Both membrane permeation profi les, however, can be analyzed as a one-layered diffusion membrane. In the present experiments, the receiver solution was always assumed to be in the sink condition. Equations 2 -4 can be written using Fick s law of diffusion; P, the permeability coeffi cient, D, the diffusion coeffi cient in the skin barrier, and K, the partition coefficient from the donor compartment to the skin barrier, were determined 25 .
The thicknesses of the intact and stripped hairless rat skin, and of LSE-high were 20 μm, 580 μm, and 20 μm, respectively 24, 26 .
In the equations, t lag is the lag time to reach steady-state skin-permeation, J ss is the steady-state fl ux, and C d is the concentration of calcein in the donor solution.
Preparation of skin slices
After the permeation experiments, the intact and stripped hairless rat skin and the LSE-high were washed with pH 7.4 phosphate buffer containing EDTA 2Na at a concentration of 1 mM. Each sample was then embedded in Tissue-Tek ® OTC compound Sakura Fine Tech Japan
Co., Ltd., Tokyo, Japan and frozen in isopentane using liquid nitrogen at 20 . The frozen tissues were sliced into horizontal slices of about 20 μm using a Cryostat CM3050S; Leica Microsystems Japan . The specimens were observed under a fl uorescence microscope.
MTT assay
Skin irritation caused by the LC dispersions was evaluated by skin viability using the MTT 3-4,5-dimethylthiazol-2-yl -2,5-diphenyltetrazolium bromide assay 27, 28 . Calceinfree LC-A and LC-B dispersions, and 2 Pluronic F127 solution were evaluated. Distilled water and 10 sodium dodecyl sulfate SDS were used as negative and positive controls, respectively. The samples 0.5 mL each were applied in a glass chamber with an effective diffusion area of 1.0 cm 2 to the abdominal skin intact or stripped of hairless rats, anesthetized by i.p. injections of urethane at a dose of 1.0 g/kg, for 8 h. The treated skin sites were excised and a 6.0-mm diameter skin sample was obtained using a biopsy punch. MTT solution 2.0 mL was added to an assay tray containing the skin sample and incubated at 37 under bubbled CO 2 /O 2 5 /95 . The MTT was adjusted to 0.333 mg/mL using DMEM medium. After incubation, excess MTT was washed off with distilled water and the skin sample was moved to a microtube. 0.04 N HCl-isopropyl alcohol 1.0 mL was added to the tube; the skin was minced using scissors. The samples were kept for 12 h with agitation to extract formazan. The obtained formazan was spectrophotometrically determined at 570 nm. The obtained value was adjusted with respect to skin weight.
Statistical analysis
The Mann-Whitney U-test was used for statistical analysis of the cumulative amount of calcein permeating the skin, and viability of the cutaneous cells. P 0.05 was considered to be signifi cant. LC-B. As in the case of cryo-TEM photographs of cubic LCs prepared from monoolein and oleic acids 13, 14 , LC structures were observed in Pluronic solutions of LC-A and LC-B in the present study white circles in Fig. 1 . Figure 2 shows the electronic diffraction patterns of the LCs determined from the cryo-TEM photographs. It was found from these diffraction patterns that LC-A was hexagonal, with a 4.6 nm periodic structure A-2 dashed lines in Fig. 2 , and LC-B was cubic, with two periodic structures of cycles 6.0 nm and 9.0 nm B-2 dashed lines in Fig. 2 . SAXS patterns were used to determine the LC structures. The crystal structures and lattice parameters can be determined from the interlayer spacing. Figure 3 shows the observed X-ray diffraction profiles of LC-A and LC-B nanodispersions, and Table 2 summarizes the peak positions and ratios of the diffraction spacings. In general, an LC has a specifi c diffraction spacing ratio, and each value is shown in Table 2 29 . The diffraction spacing ratio was 1:0.572:0.494 for blank LC-A and 1:0.577:0.497 for calcein-entrapped LC-A. These ratios were very similar to each other and also to 1: : :
, the values for hexagonal/reverse-hexagonal LCs, suggesting that the LC formulation prepared from crude terpenoid ester 1 must be reverse hexagonal. The diffraction spacing ratio was 1:0.697:0.572 for blank LC-B, and 1:0730:0.591 for calcein-entrapped LC-B. These ratios are similar to that of a cubic bicontinuous LC structure 1: : : . Table 3 shows the physicochemical properties of the LC nanodispersions prepared in this experiment. No great dif- ference was observed between the particle diameters of the LC-A and LC-B formulations. The blank LC formulations were white and turbid for both LC-A and LC-B. The calcein-entrapping ratio in LC-A was much higher than that in LC-B. If we use another compound of different lipophilicity and molecular weight, the entrapping ratio may be different. The present blank LC formulations were very stable for a long time period, as evaluated by their particle diameters and X-ray diffraction pattern. Figure 4 shows the time course of calcein permeation through excised hairless rat skin from reverse-hexagonal liquid crystal LC-A formulations. In intact and stripped skin, the skin permeations of calcein in the LC-A formulation were 3 times and 10 times higher, respectively, than the permeation of free calcein. In addition, the mixture of LC-A dispersion and free calcein showed similar skin permeation to that of free calcein solution. Thus, the blank LC formulation itself did not have any penetration-enhancement effect. The surfactant Pluronic F-127 did not show any enhancement effect data not shown . Permeation parameters were determined by the time course of the cumulative level of skin permeation. The calculated parameters are shown in Table 4 . The partition coefficient, K, was markedly increased by addition of the LC-A formulation, suggesting that LC-A is highly distributed from the dispersion to the skin surface stratum corneum .
Evaluation of physicochemical properties of liquidcrystal dispersions
Skin-penetration-enhancing effect of liquid crystals
Next, the time course of skin permeation of calcein from the cubic liquid-crystal dispersion LC-B was evaluated; the results are shown in Fig. 5 . Enhanced permeation of 
Skin-permeation-enhancing Effect of Liquid-Crystal
calcein through hairless rat skin was observed with LC-B as well as with LC-A; Table 5 summarizes the permeation parameters for LC-B. Increased partition of calcein was observed with LC-B, as well as with LC-A. No partition increase was observed for stripped skin with LC-B, unlike the case with LC-A. Determination of the physical and chemical properties of LC-A and LC-B is diffi cult, and the ratio of LC in each formulation was uncertain. LC-A had a high affi nity for both the stratum corneum and the viable epidermis, whereas LC-B showed a high affinity for the stratum corneum, but not for the viable epidermis. Identification of suitable LCs is an issue which needs to be discussed. Similar permeation experiments were carried out using a three-dimensional cultured human-skin model, LSE-high.
The data are shown in Fig. 6 and Table 6 . LC-A showed a high enhancement effect on the skin permeation of calcein. Since LC would increase the partitioning of an entrapped drug into the stratum corneum, the penetration-enhancement effect by LC formulations would also be obtained for the stratum corneum barrier. Fig. 7F . In contrast, a much higher fl uorescent level was found for the calceinentrapped LC-A dispersion Fig. 7D . These results were refl ected by the skin-permeation data for LC-A dispersions
Figs. 4 and 6 . Liposomes and micelles have also been found to increase the skin permeation of compounds 30 . It is necessary to compare the skin-permeation-enhancing effects of the present LCs with those of liposomes and micelles. This is, however, very diffi cult at this stage. This is because the lipids used to make LCs, lipsomes, and micelles are generally different. Further trials are necessary to compare the enhancing effects of LCs, liposomes, and micelles which have all been prepared using the same or similar lipids.
Skin irritation by liquid-crystal formulations
Skin irritation by the LC formulations was evaluated by MTT assays in hairless rats. The obtained data for the viability of cutaneous cells are summarized in Fig. 8 . No irritation no decrease in viability was observed for any group evaluated in this experiment when the sample was applied to intact hairless rat skin Fig. 8a . Tape-stripped skin was used to evaluate the safety of the LC formulations. A positive control, 10 SDS, decreased the viability of skin tissue compared to the saline group. On the other hand, no decrease in viability was observed for the two LC groups LC-A and LC-B . These results suggest that these LC formulations are safe formulation materials for skin applications.
CONCLUSION
It was found from cryo-TEM observations, electron diffraction patterns, and small-angle X-ray diffraction analysis that these LC-A and LC-B nanodispersions have reversehexagonal LC and cubic LC dispersions, respectively. These LC dispersions were very stable, since no aggrega- tion diameter growth , and little change in the LC structure change in X-ray diffraction pattern , were observed. The entrapping ratio of a hydrophilic model compound, calcein, in LC-B was higher than that in LC-A, suggesting that cubic LC has a greater entrapping potency for hydrophilic materials. Other drugs with different lipophilicities and molecular weights must be examined in the future. The present skin-permeation experiments showed that LC-A and LC-B nanodispersions increased the skin permeation of the entrapped drug, probably as a result of increased partitioning of the LC in the skin barrier. Since the lamellar structure and lipophilicity of LCs are similar to those in the stratum corneum, the LC formulation probably increased partition of calcein into the stratum corneum, resulting in enhanced skin permeation. In addition, no skin irritation was caused by the LC dispersions. Thus, these LC formulations can be used as new topical formulations for therapeutic drugs and cosmetic ingredients, especially for hydrophilic compounds. The content of the entrapped drugs in the skin must be determined, and detailed mechanistic analyses performed, in the near future.
